Literature DB >> 10752568

Waking up to sleep episodes in Parkinson's disease.

C W Olanow1, A H Schapira, T Roth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10752568     DOI： 10.1002/1531-8257(200003)15:2<212::aid-mds1002>3.0.co;2-6

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  22 in total

Review 1.  Emerging therapies in the pharmacological treatment of Parkinson's disease.

Authors:  Amos D Korczyn; Miri Nussbaum
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Neurologic conditions: assessing medical fitness to drive.

Authors:  Steven H Yale; Phiroze Hansotia; Dawn Knapp; John Ehrfurth
Journal:  Clin Med Res       Date:  2003-07

Review 3.  Epidemiology of Parkinson's disease.

Authors:  Guido Alves; Elin Bjelland Forsaa; Kenn Freddy Pedersen; Michaela Dreetz Gjerstad; Jan Petter Larsen
Journal:  J Neurol       Date:  2008-09       Impact factor: 4.849

4.  Effect of cabergoline added to levodopa treatment on sleep-wake cycle in idiopathic Parkinson's disease: an open label 24-hour polysomnographic study.

Authors:  A Romigi; P Stanzione; M G Marciani; F Izzi; F Placidi; A Cervellino; P Giacomini; L Brusa; K Grossi; M Pierantozzi
Journal:  J Neural Transm (Vienna)       Date:  2006-06-01       Impact factor: 3.575

Review 5.  Early versus delayed initiation of pharmacotherapy in Parkinson's disease.

Authors:  Matthias Löhle; Carl-Johan Ramberg; Heinz Reichmann; Anthony H V Schapira
Journal:  Drugs       Date:  2014-04       Impact factor: 9.546

Review 6.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

7.  Sleepiness and Unintended Sleep in Parkinson's Disease.

Authors:  David B. Rye
Journal:  Curr Treat Options Neurol       Date:  2003-05       Impact factor: 3.598

Review 8.  Sleep disorders in patients with Parkinson's disease: epidemiology and management.

Authors:  J P Larsen; E Tandberg
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 9.  Sleep attacks and dopamine agonists for Parkinson's disease: what is currently known?

Authors:  Theresa A Zesiewicz; Robert A Hauser
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

10.  Sleep disorders in Parkinson's disease.

Authors:  Israt Jahan; Robert A Hauser; Kelly L Sullivan; Amber Miller; Theresa A Zesiewicz
Journal:  Neuropsychiatr Dis Treat       Date:  2009-11-02       Impact factor: 2.570
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.